ISoOR Insight Team (2026) “Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025”, Journal of Organoid and Bioscience, 3(1). Available at: https://jobs.isoor.org/index.php/journal/article/view/57 (Accessed: 3 March 2026).